Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lianqiao Jinbei Decoction is a traditional Chinese medicine (TCM) herbal formula used for the treatment of **HER2-positive breast cancer** and other conditions associated with internal heat and toxicity[1][7][13]. Its primary mechanism involves **multi-component, multi-target action**, where core active ingredients such as quercetin, β-sitosterol, and luteolin suppress tumor cell proliferation and migration and promote apoptosis mainly by inhibiting expression of the **HER2 protein** in HER2-positive breast cancer cells[1][11]. Network pharmacology and experimental data indicate the decoction regulates HER2 protein, leading to effective tumor suppression[1][11]. The formula is also known in TCM for **clearing heat, detoxifying, reducing swelling, and invigorating the blood**[7][9]. It is used in practice for conditions such as sores, abscesses, and Yang toxicity with internal heat[7][13]. Lianqiao Jinbei Decoction is customarily prepared from a combination of herbs and administered as an oral decoction. Its principal indications in research are HER2-positive breast cancer and symptoms of internal heat/toxicity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Lianqiao Jinbei Decoction.